Banque Cantonale Vaudoise’s Royalty Pharma RPRX Stock Holding History

Banque Cantonale Vaudoise’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$119	Hold	2,120	–	–	﹤0.01%	690
2026 Q1	$102K	Buy	+2,120	New	+$92.8K	﹤0.01%	713
2023 Q4	–	Sell	-7,200	Closed	-$196K	–	1167
2023 Q3	$196K	Hold	7,200	–	–	0.01%	684
2023 Q2	$222K	Hold	7,200	–	–	0.01%	691
2023 Q1	$260K	Hold	7,200	–	–	0.01%	633
2022 Q4	$284K	Hold	7,200	–	–	0.01%	614
2022 Q3	$289K	Hold	7,200	–	–	0.02%	616
2022 Q2	$302K	Sell	7,200 -1,100	-13%	-$45.1K	0.02%	630
2022 Q1	$324K	Hold	8,300	–	–	0.01%	680
2021 Q4	$331K	Hold	8,300	–	–	0.01%	706
2021 Q3	$300K	Hold	8,300	–	–	0.01%	711
2021 Q2	$340K	Buy	+8,300	New	+$353K	0.02%	711

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Banque Cantonale Vaudoise's RPRX Position: Q2 2026 in Review

Banque Cantonale Vaudoise held its Royalty Pharma (RPRX) position steady in Q2 2026 at 2,120 shares worth $119. The position accounts for ﹤0.01% of the portfolio, ranked #690.

Banque Cantonale Vaudoise first reported a position in RPRX in Q2 2021 and has held it in 12 quarters since. The position peaked at $340K in Q2 2021. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Banque Cantonale Vaudoise held 2,120 shares of Royalty Pharma worth $119 as of Q2 2026.
Banque Cantonale Vaudoise left its Royalty Pharma share count unchanged in Q2 2026.
Royalty Pharma made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q2 2026, its #690 holding.
Banque Cantonale Vaudoise first reported a position in Royalty Pharma in Q2 2021 and has held it in 12 quarters since.
Banque Cantonale Vaudoise's Royalty Pharma position peaked at $340K in Q2 2021.
645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.